Core Viewpoint - The company reported a significant increase in revenue and profit for the six months ending June 30, 2025, driven by successful international expansion and foreign exchange gains [1] Financial Performance - The group's operating revenue reached approximately RMB 1.266 billion, representing a year-on-year increase of about 16.4% [1] - The profit attributable to shareholders was approximately RMB 184 million, an increase of about RMB 178 million compared to the same period in 2024 [1] - Basic and diluted earnings per share were RMB 2.97 [1] Strategic Progress - The company's internationalization strategy has made substantial progress, contributing significantly to revenue growth from overseas market orders [1] - The increase in foreign exchange gains compared to the same period in 2024 also played a role in the profit increase [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因依賴該等內容而引致之任何損失承擔任何責任。 Yuanda China Holdings Limited 遠 大 中 國 控 股 有 限 公 司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：2789） 截至2025年6月30日止六個月未經審核中期之業績公佈 遠大中國控股有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈本公司及其附屬 公司（統稱「本集團」）截至2025年6月30日止六個月（「報告期間」）之未經審核中期業績。 本集團報告期內之中期財務資料未經審核，惟已經本公司審核委員會（「審核委員會」）審 閱。 | | 截至2025年 | 截至2024年 | | --- | --- | --- | | | 6月30日止 | 6月30日止 | | 財務摘要 | 六個月 | 六個月 | | | （概約） | （概約） | | （人民幣百萬元） 收入 | 1,266.3 | 1,088.2 | | （附註） 經調 ...

Core Viewpoint - Yuan Da China (02789) has seen a significant stock price increase of nearly 25%, currently trading at 0.191 HKD, with a transaction volume of 10.4792 million HKD. The company is set to hold a board meeting on August 29 to approve its mid-year performance, with expected net profits between 150 million to 210 million CNY, a substantial increase from 6 million CNY in the same period last year. The growth in net profit is attributed to the successful implementation of the company's internationalization strategy and significant contributions from overseas market orders, as well as increased foreign exchange gains compared to the same period in 2024 [1]. Group 1 - Yuan Da China is an independent listed company primarily engaged in curtain wall construction, recognized as one of the first companies in China to obtain Grade A design and Grade 1 construction qualifications for building curtain walls. It is also designated as a key enterprise for building curtain walls by the Ministry of Construction of China, positioning itself as a leading global player in the curtain wall industry [1]. - The company provides comprehensive one-stop curtain wall solutions to clients, with its business operations widely distributed globally. In 2024, the company's revenue from China reached 1.02 billion CNY, accounting for 46% of total revenue. The United States and the United Kingdom followed, each contributing approximately 240 million CNY, representing around 11% of total revenue. Qatar generated 200 million CNY, accounting for 9% of total revenue [1].

Core Viewpoint - Yuan Da China (02789) has seen a significant stock price increase of approximately 25%, currently trading at 0.191 HKD, with a transaction volume of 10.48 million HKD. The company is set to hold a board meeting on August 29 to approve its mid-year performance, with expected net profits between 150 million to 210 million CNY, a substantial increase from 6 million CNY in the same period last year. This growth is attributed to the successful implementation of the company's internationalization strategy and increased contributions from overseas market orders, as well as foreign exchange gains compared to the same period in 2024 [1]. Group 1 - The company anticipates a net profit of approximately 150 million to 210 million CNY for the first half of the year, compared to 6 million CNY in the same period last year [1]. - The increase in net profit is primarily due to the progress of the company's internationalization strategy and significant contributions from overseas market orders [1]. - The company reported an increase in revenue and foreign exchange gains compared to the same period in 2024 [1]. Group 2 - Yuan Da China is recognized as a leading global enterprise in the construction curtain wall industry, being one of the first independent listed companies in China approved for Grade A design and Grade 1 construction of curtain walls [1]. - The company's business model provides comprehensive curtain wall solutions to clients, with operations spread globally [1]. - In 2024, the company's revenue from China was 1.02 billion CNY, accounting for 46% of total revenue, followed by the United States and the United Kingdom, each contributing approximately 240 million CNY, or 11% [1].

Core Viewpoint - Far East China (02789) has seen a significant stock price increase of nearly 25%, currently trading at 0.191 HKD, with a transaction volume of 10.4792 million HKD, ahead of its mid-year earnings announcement scheduled for August 29 [1] Financial Performance - The company anticipates a net profit of approximately 150 million to 210 million CNY for the first half of the year, compared to 6 million CNY in the same period last year [1] - The growth in net profit is attributed to the successful implementation of the internationalization strategy, which has led to substantial contributions from overseas market orders and an increase in foreign exchange gains compared to the same period in 2024 [1] Business Overview - Shenyang Far East (Far East China) is an independent listed company primarily engaged in curtain wall construction, recognized as one of the first approved companies for Grade A design and Grade 1 construction in China [1] - The company provides comprehensive curtain wall solutions and has a global business presence [1] Revenue Breakdown - In 2024, the company's revenue from China is projected to be 1.02 billion CNY, accounting for 46% of total revenue, making it the largest revenue region [1] - The United States and the United Kingdom are the second-largest markets, each contributing approximately 240 million CNY, representing about 11% of total revenue [1] - Revenue from Qatar is expected to be 200 million CNY, accounting for 9% of total revenue [1]

Market Overview - The Hong Kong stock market continued its downward trend, with all three major indices in the red but maintaining above the 25,000 mark. The Hang Seng Index closed down 0.98% at 25,270.07 points, with a total turnover of HKD 31.27 billion [1] - Short-term market focus is on mid-year performance and cost-effectiveness, with potential volatility from US-China trade negotiations and fluctuations in US stocks [1] Blue-Chip Stocks Performance - JD Health (06618) led blue-chip stocks, rising 11.67% to HKD 61.25, contributing 11.31 points to the Hang Seng Index. The company's H1 2025 performance exceeded market expectations due to strong growth in the pharmaceutical category [2][4] - Other notable blue-chip movements included Xinyi Solar (00968) up 5.96%, Alibaba Health (00241) up 4.92%, while New World Development (00016) and Henderson Land (00012) saw declines of 5.35% and 4.63% respectively [2] Sector Highlights - Internet healthcare stocks showed strong performance, with Dingdang Health (09886) up 36.07% and JD Health (06618) up 11.67% following strong mid-year results [3][4] - The brokerage sector saw significant gains, with CITIC Securities (06066) up 10.98% and Zhongtai Securities (01375) up 9.03%, reflecting a structural shift in fund flows towards financial markets [5][6] - The photovoltaic sector also experienced gains, driven by a shortage and price increases in solar components, with Xinyi Solar (00968) rising 8.15% [6][7] Regulatory Developments - The Hong Kong Monetary Authority and the Securities and Futures Commission issued a joint statement regarding recent market fluctuations related to stablecoins, emphasizing a cautious approach to licensing [8] Notable Stock Movements - Silver诺医药-B (02591) surged 206.48% on its debut, reflecting strong market interest in GLP-1 drug treatments [9] - Liken Technology (00558) rose 46.02% following a strategic partnership for magnesium alloy humanoid robot development [10] - Far East China (02789) saw an 84.34% increase after announcing a profit forecast for H1 2025, driven by international market orders [11][12] - Jin Hai Medical Technology (02225) fell 50.56% after announcing a share subscription at a discount to market price [13]

董事會會議通知 Yuanda China Holdings Limited 2789 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部分內容 而產生或因依賴該等內容而引致之任何損失承擔任何責任。 遠大中國控股有限公司（「本公司」）董事會（「董事會」）謹此通知，董事會會議將於2025年8 月29日（星期五）舉行，以考慮及酌情通過（其中包括）本公司及其附屬公司截至2025年6月 30日止六個月之未經審核合併中期業績及其刊發及處理任何其他事項（如有）。 承董事會命 遠大中國控股有限公司 於本公告日期，本公司執行董事為康寶華先生、趙忠秋先生、王昊先生及張雷先生；及 本公司獨立非執行董事為王宇航先生、楊倩雯女士及哈剛先生。 主席 康寶華 中國，2025年8月15日 ...

8月14日，远大中国发布公告，该集团预期于2025年上半年取得净利润约1.5亿至2.1亿元，2024年同期净 利润为600万元。公告称，净利增长的主要原因是该期间内集团国际化战略取得良好进展，海外市场订 单贡献突出，使得集团该期间的收入规模较2024同期取得增长，及该期间集团汇兑收益较2024年同期取 得增长。 来源：新浪港股 远大中国（02789）盈喜后飙升逾60%，截至发稿，股价上涨56.63%，现报0.130港元，成交额527.041万 港元。 ...

智通财经获悉，远大中国(02789)盈喜后飙升逾60%，截至发稿，涨60.24%，报0.133港元，成交额 317.44万港元。 消息面上，8月14日，远大中国发布公告，该集团预期于2025年上半年取得净利润约1.5亿-2.1亿元， 2024年同期净利润为600万元。公告称，净利增长的主要原因是该期间内集团国际化战略取得良好进 展，海外市场订单贡献突出，使得集团该期间的收入规模较2024同期取得增长，及该期间集团汇兑收益 较2024年同期取得增长。 本文源自：智通财经网 ...

Core Viewpoint - Far East Global (02789) experienced a surge of over 60% in stock price following a profit warning, with shares trading at HKD 0.133 and a transaction volume of HKD 3.1744 million [1] Group 1: Financial Performance - The company anticipates a net profit of approximately HKD 150 million to HKD 210 million for the first half of 2025, compared to a net profit of HKD 6 million in the same period of 2024 [1] - The significant increase in net profit is attributed to the successful implementation of the company's internationalization strategy, which has led to substantial contributions from overseas market orders [1] Group 2: Revenue Growth - The company expects revenue growth for the period compared to the same period in 2024, driven by increased orders from international markets [1] - Additionally, the company reported an increase in foreign exchange gains compared to the same period in 2024, further contributing to the anticipated profit growth [1]